Mina Hosseini

561 total citations
22 papers, 409 citations indexed

About

Mina Hosseini is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mina Hosseini has authored 22 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Mina Hosseini's work include Selenium in Biological Systems (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Mina Hosseini is often cited by papers focused on Selenium in Biological Systems (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Mina Hosseini collaborates with scholars based in Iran, United States and United Arab Emirates. Mina Hosseini's co-authors include Soodabeh Shahidsales, Seyed Mahdi Hassanian, Mina Maftouh, Amir Avan, Majid Ghayour‐Mobarhan, Safieh Ebrahimi, Gordon A. Ferns, Mojtaba Shafiee, Reza Nedaeinia and Nima Rezaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of the American Geriatrics Society.

In The Last Decade

Mina Hosseini

19 papers receiving 404 citations

Peers

Mina Hosseini

ONCOL

IMMUN

PRM

Fatemeh Ezzatifar Iran

Zhaoyu Liu China

Hitendra S. Solanki United States

Sayed Mostafa Hosseini Iran

Huiting Zhu China

Hyeon‐Gun Jee South Korea

Congmin Zhang China

Yulong Zheng China

Zahra Bahmanpour Iran

Handong Jiang China

Fatemeh Ezzatifar Iran

Mina Hosseini

228 ×1.0

78 ×0.5

67 ×0.6

ONCOL

92 ×1.8

IMMUN

25 ×0.8

PRM

Citations per year, relative to Mina Hosseini Mina Hosseini (= 1×) peers Fatemeh Ezzatifar

Countries citing papers authored by Mina Hosseini

Since Specialization

Citations

This map shows the geographic impact of Mina Hosseini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Hosseini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Hosseini more than expected).

Fields of papers citing papers by Mina Hosseini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Hosseini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Hosseini. The network helps show where Mina Hosseini may publish in the future.

Co-authorship network of co-authors of Mina Hosseini

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Hosseini. A scholar is included among the top collaborators of Mina Hosseini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Hosseini. Mina Hosseini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fatahi, Yousef, et al.. (2025). Boosting breast cancer immunotherapy through targeted siRNA delivery and sequential chemotherapy. Journal of drug targeting. 33(10). 1902–1913.

Amirkhizi, Farshad, et al.. (2025). Adherence to combined healthy lifestyle and odds of metabolic syndrome in Iranian adults: the PERSIAN Dena cohort study. Scientific Reports. 15(1). 5164–5164. 1 indexed citations

Hosseini, Mina, et al.. (2024). PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer. Frontiers in Oncology. 14. 1357801–1357801. 10 indexed citations

Hosseini, Mina, Ahmad Reza Shahverdi, Jamshid Hadjati, et al.. (2024). Generation of Murine Chimeric Antigen Receptor‐Modified T Cells for In Vivo Studies in Syngeneic Tumor Models. Current Protocols. 4(8). e1107–e1107.

Hosseini, Mina, et al.. (2023). Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review. Vaccines. 11(1). 146–146. 27 indexed citations

Faghfuri, Elnaz, et al.. (2023). The Cytotoxicity of Tellurium Nanoparticles on Different Cell Lines and Their in vivo Anticancer Effects in an Animal Model. SHILAP Revista de lepidopterología.

Hosseini, Mina, et al.. (2022). The Future of Artificial Intelligence in Monitoring Animal Identification, Health, and Behaviour. Animals. 12(13). 1711–1711. 29 indexed citations

Hosseini, Mina, et al.. (2021). Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review. Expert Opinion on Biological Therapy. 22(3). 349–366. 4 indexed citations

Faghfuri, Elnaz, et al.. (2021). Fabrication of Calcium Sulfate Coated Selenium Nanoparticles and Corresponding In-Vitro Cytotoxicity Effects Against 4T1 Breast Cancer Cell Line.. PubMed. 13(4). 201–206. 1 indexed citations

10.

Shabani, Mahsima, et al.. (2020). Neuroblastoma‐targeted nanoparticles and novel nanotechnology‐based treatment methods. Journal of Cellular Physiology. 236(3). 1751–1775. 7 indexed citations

11.

Khalili, Parvin, Mohsen Rezaeian, Abdolhalim Rajabi, et al.. (2019). Geographical distribution of death due to cancer in Kerman Province, Southeast Iran (2012-2016): A comparison of proportional mortality and age-adjusted mortality rate. Iranian Journal Of Health Sciences. 1 indexed citations

12.

Hosseini, Mina, Vahid Shaygannejad, Shahriar Nafissi, et al.. (2018). High Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction after Thymectomy. NeuroImmunoModulation. 25(2). 80–88. 9 indexed citations

13.

Hosseini, Mina, et al.. (2017). Increased Proportion of Tc17 and Th17 Cells and Their Significant Reduction after Thymectomy May Be Related to Disease Progression in Myasthenia Gravis. NeuroImmunoModulation. 24(4-5). 264–270. 8 indexed citations

14.

Hosseini, Mina, Seyed Mahdi Hassanian, Soodabeh Shahidsales, et al.. (2017). Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives. Journal of Cellular Biochemistry. 118(7). 1634–1638. 31 indexed citations

15.

Gruber‐Baldini, Ann L., Mina Hosseini, Denise Orwig, et al.. (2017). Cognitive Differences between Men and Women who Fracture their Hip and Impact on Six‐Month Survival. Journal of the American Geriatrics Society. 65(3). e64–e69. 21 indexed citations

16.

Ebrahimi, Safieh, Mina Hosseini, Soodabeh Shahidsales, et al.. (2017). Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. Current Medicinal Chemistry. 24(13). 1321–1331. 139 indexed citations

17.

Ebrahimi, Safieh, Mina Hosseini, Faezeh Ghasemi, et al.. (2016). Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer. Current Pharmaceutical Design. 22(42). 6444–6450. 30 indexed citations

18.

Hosseini, Mina, Seyed Mahdi Hassanian, Reza Nedaeinia, et al.. (2016). Exosome-Encapsulated microRNAs as Potential Circulating Biomarkers in Colon Cancer. Current Pharmaceutical Design. 23(11). 1705–1709. 86 indexed citations

19.

Hosseini, Mina. (2007). Stochastic modeling of oil futures prices. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1 indexed citations

20.

Emami, Mohammad Jafar, et al.. (2005). PREVALENCE OF FLEXIBLE FLAT FOOT IN MALE CHILDREN. 3(4). 59–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact